GlassScriptPhysician profile
James J Kinchsular
NPI 1346440971
$6,372.43
in general payments reported to CMS, 2019-2025
10 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,803 · 2020: $1,045 · 2021: $1,632 · 2022: $221 · 2023: $640 · 2024: $746 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,549.64 | 2019-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Actishield |
| Sequoia Surgical, INC. | $1,212.00 | 2021 | |
| Treace Medical Concepts, INC. | $1,012.99 | 2020-2025 | |
| Evolution Surgical, INC | $145.41 | 2023-2024 | |
| Bioventus LLC | $119.60 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate |
| Nevro Corp. | $117.68 | 2021 | |
| Next Science LLC | $112.36 | 2022 | |
| Orthofix Medical, INC. | $66.74 | 2019 | |
| Smith+Nephew, INC. | $22.05 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.96 | 2023 | Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kinchsular listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.